Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
40%(4 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
5
38%
Ph phase_3
2
15%
Ph early_phase_1
1
8%
Ph phase_4
4
31%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
4(30.8%)
N/ANon-phased studies
5(38.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Terminated(1)
Other(2)

Detailed Status

Completed10
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 32 (15.4%)
Phase 44 (30.8%)
N/A5 (38.5%)

Trials by Status

terminated18%
completed1077%
unknown215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13